Idiopathic Pulmonary Fibrosis Education | Idiopathic Pulmonary Fibrosis CME/CE Learning Center

Webinars

Search

Saved Activities

0 Activities

0 Activities

Filter Content

Idiopathic Pulmonary Fibrosis

Free online continuing education on Idiopathic Pulmonary Fibrosis! Get quality activities, articles, & videos to improve your Idiopathic Pulmonary Fibrosis education.

Page 1 of 2

Results 1 - 75 of 117

9368-bronchiectasis

Rapid Recap: Considering a Comprehensive Approach for Bronchiectasis Management

9368-bronchiectasis

Considering a Comprehensive Approach for Bronchiectasis Management

Improving the Diagnosis and Management of PPF: Rapid Recap

Improving the Diagnosis and Management of PPF: A Focus on SSc-ILD and IPF

9360-0001_263x149

Improving the Management of Patients with PPF - Slide Library

9102-chest-slides

IPF Management and Antifibrotic Therapy - Slide Deck

9088-ipf-slides

A Collaborative Approach to IPF Management - Slide Deck

IPF Management and Antifibrotic Therapy

A Collaborative Approach to IPF Management

Patient Develops de novo Features of ILD After a COVID Infection

SSc-ILD Individualized Treatment

Overlapping Symptoms and Risk Factors for COVID and IPF

Multidisciplinary Management of IPF

Fundamentals of Diagnosis: SSc-ILD

Fundamentals of Diagnosis: PF-ILD

IPF Management in Practice: A Truly Interactive Experience

Management of Patients With IPF: Virtual Conference Coverage

Clinical Pearls from New Orleans 2019

Inhaled NO in Patients at Risk for Pulmonary Hypertension

Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease

Considerations for Geriatric ILD Patients

Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease

Emerging Diagnostic Approaches to Patients with ILD

Goals of Care Across the Disease Continuum in IPF

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Current Perspective on Antifibrotic Therapy for Patients with IPF

Pulmonologists as the Gatekeepers of Precision Medicine

Interstitial Pneumonia with Autoimmune Features (IPAF)

How to Identify & Manage Patients with Progressive-Fibrosing ILD

Acute Exacerbations of IPF

9815-developments

New Developments in Pulmonary Diseases: Optimizing Patient Outcomes

9815-palliative slides

Palliative Medicine in Pulmonology

Thoracic Radiology

Mechanisms of Action of Biologic Therapies for Severe Asthma

9907-0006_shared

Engage Your Patients in Shared Decision-Making

9907-0005_cardio

Is It IPF or Cardiovascular Disease?

Interstitial Pneumonia with Autoimmune Features

9907-0003_pf-ild

How to Identify Progressive Fibrosing ILD

When Is It a Connective Tissue Disease?

9907-0001_guidelines

How to Use IPF Guidelines to Make a Diagnosis

Advanced Care Planning and Palliative Care Models for Patients with IPF

Dyspnea Assessment in Patients with IPF

Which Patients with IPF Should be on Antifibrotics?

The Impact of Anticoagulation Use on IPF Patient Outcomes

Patient-Centered Outcomes for Patients with IPF: Activity Monitoring

Connective Tissue Disease-Related ILD is Now in the Limelight

Biomarkers in IPF and Other ILDs

9840-glassberg2

Evaluation and Diagnosis of IPF

9840-glassberg1

Initial Treatment Decisions of IPF

Optimizing Management of IPF

What are the Most Exciting Things Happening in Pulmonary Disease?

When Is a Cough Not Just a Cough?

Diagnosing ILDs Such as IPF and More

Beyond the Basics: Complex ILD Cases

Shedding Light on Jane’s ILD Diagnosis

9815-palliative

When Should You Consider Palliative Care in the Patient Journey?

What is Your Treatment Recommendation for Sandra’s CTEPH?

Tracy Has Chest Palpitations and Cough: What Does Her Imaging Tell Us?

New Tools to Improve the Diagnosis of IPF vs Other ILDs

New Research on Therapies for Patients with Pulmonary Fibrosis

The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD

2019 Summer Pulmonary Updates: The Experts Weigh In

Reporting HRCT Findings for ILD from a Multidisciplinary Team

The Latest from a Recent Pulmonary Conference in San Antonio

The Importance of Early Integration of Palliative Care

Management of IPF Patients in 2018

Updates in the Diagnosis of ILD and the Role of Cryobiopsy

Overview of the Latest Clinical Trials in IPF

Evolution of Antifibrotic Therapy in IPF

Take Home Messages from the 2018 CHEST Annual Meeting

What We’re Learning from the IPF-PRO Registry

Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines

Practice_Improvement_through_ILD_Centers_264x150

Practice Improvement through ILD Centers and Community Partnerships

Improving_the_Care_for_IPF_Patients_264x150

Improving the Care for IPF Patients Using a Team-Based Approach

An_Early_Integrated_Palliative_Care_264x150

An Early Integrated Palliative Care Delivery Model for Patients with IPF

Page 1 of 2